Not logged in Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial Gogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik Share Save
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT Ivesono, Timothy; Boydo, Kathleen A.; Kerro, Rachel S.; Robles-Zuritao, Jose; Saunders, Mark P.; Briggso, Andrew H.; Cassidyo, Jim; Hollandero, Niels Henrik; Taberneroo, Josep; Haydon, Andrew; Glimeliuso, Bengt; Harkino, Andrea; Allano, Karen; McQueeno, John; Pearsono, Sarah; Waterstono, Ashita; Medleyo, Louise; Wilsono, Charles; Elliso, Richard; Essapen, Sharadah; Dhaddao, Amandeep S.; Harrison, Mark; Falko, Stephen; Raoufo, Sherif; Rees, Charlotte; Oleseno, Rene K.; Proppero, David; Bridgewatero, John; Azzabio, Ashraf; Farrugiao, David; Webbo, Andrew; Cunninghamo, David; Hickish, Tamas; Weavero, Andrew; Gollins, Simon; Wasano, Harpreet; Paulo, James Share Save
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer Robles-Zurita, Jose; Boyd, Kathleen A.; Briggs, Andrew H.; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Segelov, Eva; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S.; Hughes, Rob; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet S.; Paul, James Share Save
Share Save
A phase 2, fast real-time assessment of combination therapies in immuno-oncology trial in patients with advanced non-small cell lung cancer (FRACTION-lung) Fracasso, P. M.; Freeman, D. J.; Simonsen, K.; Shen, Y.; Gupta, M.; Comprelli, A.; Gainor, J. F.; Hellmann, M.; Chow, L. Q.; Forde, P. M.; Govindan, R.; Reilly, T. P.; Cassidy, J. Share Save
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer Hickish, Tamas; Cassidy, Jim; Propper, David; Chau, Ian; Falk, Stephen; Ford, Hugo; Iveson, Tim; Braun, Michael; Potter, Vanessa; Macpherson, Iain R.; Finnigan, Helen; Lee, Chooi; Jones, Hilary; Harrison, Mark Share Save
Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial Chu, E.; Haller, D.; Cartwright, T.; Twelves, C.; Cassidy, J.; Sun, W.; Saif, M. W.; McKenna, E.; Lee, S.; Schmoll, H-J Share Save
Share Save
Share Save
Share Save
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 129676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803 Sargent, D.; Shi, Q.; Yothers, G.; Van Cutsem, E.; Cassidy, J.; Saltz, L.; Wolmark, N.; Bot, B.; Grothey, A.; Buyse, M.; de Gramont, A. Share Save
Share Save
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer Cunningham, D.; Sirohi, B.; Pluzanska, A.; Utracka-Hutka, B.; Zaluski, J.; Glynne-Jones, R.; Koralewski, P.; Bridgewater, J.; Mainwaring, P.; Wasan, H.; Wang, J.-Y.; Szczylik, C.; Clingan, P.; Chan, R. T. T.; Tabah-Fisch, I.; Cassidy, J. Share Save
Share Save
A Dynamic Model of Hand-and-Foot Syndrome in Patients Receiving Capecitabine Henin, E.; You, B.; VanCutsem, E.; Hoff, P. M.; Cassidy, J.; Twelves, C.; Zuideveld, K. P.; Sirzen, F.; Dartois, C.; Freyer, G.; Tod, M.; Girard, P. Share Save
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery) Graham, Janet S.; Plummer, Ruth; McCoy, Candice; Kowal, Kristin; Wiesinger, Herbert; Detjen, Katharina; Calvert, Hilary; Wiedenmann, Bertram; Cassidy, Jim Share Save
Share Save
Share Save
Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}